Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]
News [13558]
Articles [218]
Editorials [5]
Conferences [266]
elearning [17]

Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer

Dr Maha Hussain - University of Michigan, Ann Arbor, USA
Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer ( Dr Maha Hussain - University of Michigan, Ann Arbor, USA )
3 Jun 2012

Lower-income Patients are less likely to participate in clinical trials

Dr Joseph Unger - SWOG Statistical Center, Seattle, USA
Lower-income Patients are less likely to participate in clinical trials ( Dr Joseph Unger - SWOG Statistical Center, Seattle, USA )
3 Jun 2012

Bendamustine regimen more effective for lymphoma than standard CHOP

Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Bendamustine regimen more effective for lymphoma than standard CHOP ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012

Early results from new PD-1 targeted immune therapy

Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore, USA
Early results from new PD-1 targeted immune therapy ( Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore, USA )
2 Jun 2012

New study asks patients preference on kidney cancer treatment

Dr Bernard Escudier - Institut Gustave Roussy, Paris, France
New study asks patients preference on kidney cancer treatment ( Dr Bernard Escudier - Institut Gustave Roussy, Paris, France )
2 Jun 2012

Relapse and survival of adolescent and young adult leukaemia patients

Dr Eric Larsen - Maine Children’s Cancer Program, Scarborough, USA
Relapse and survival of adolescent and young adult leukaemia patients ( Dr Eric Larsen - Maine Children’s Cancer Program, Scarborough, USA )
2 Jun 2012

Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival

Dr Eric Pujade-Lauraine - Université Paris Descartes, France
Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival ( Dr Eric Pujade-Lauraine - Université Paris Descartes, France )
2 Jun 2012

The OECI and EurocanPlatform

Prof Wim van Harten – The Netherlands Cancer Institute, Amsterdam
The OECI and EurocanPlatform ( Prof Wim van Harten – The Netherlands Cancer Institute, Amsterdam )
21 May 2012

Problems in the structure of clinical trials

Prof Thomas Tursz – Institut Gustave Roussy, Paris, France
Problems in the structure of clinical trials ( Prof Thomas Tursz – Institut Gustave Roussy, Paris, France )
21 May 2012

Heterogeneity of global cancer outcomes

Prof Reinhard Busse – Technische Universitat, Berlin, Germany
Heterogeneity of global cancer outcomes ( Prof Reinhard Busse – Technische Universitat, Berlin, Germany )
18 May 2012

New approaches to personalised medicine

Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany
New approaches to personalised medicine ( Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany )
18 May 2012

Recent developments in neoadjuvant therapy

Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Recent developments in neoadjuvant therapy ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
17 May 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation